Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 70 entries
Sorted by: Best Match Show Resources per page
Accuracy of medical models made by consumer-grade fused deposition modelling printers.

Plastic surgery (Oakville, Ont.)

Petropolis C, Kozan D, Sigurdson L.
PMID: 26090349
Plast Surg (Oakv). 2015;23(2):91-4. doi: 10.4172/plastic-surgery.1000912.

BACKGROUND: Additive manufacturing using fused deposition modelling (FDM) has become widely available with the development of consumer-grade three-dimensional printers. To be useful in maxillofacial surgery, models created by these printers must accurately reproduce the craniofacial skeleton.OBJECTIVE: To determine the...

Cite
Petropolis C, Kozan D, Sigurdson L. Accuracy of medical models made by consumer-grade fused deposition modelling printers. Plast Surg (Oakv). 2015;23(2):91-4doi: 10.4172/plastic-surgery.1000912.
Petropolis, C., Kozan, D., & Sigurdson, L. (2015). Accuracy of medical models made by consumer-grade fused deposition modelling printers. Plastic surgery (Oakville, Ont.), 23(2), 91-4. https://doi.org/10.4172/plastic-surgery.1000912
Petropolis, Christian, et al. "Accuracy of medical models made by consumer-grade fused deposition modelling printers." Plastic surgery (Oakville, Ont.) vol. 23,2 (2015): 91-4. doi: https://doi.org/10.4172/plastic-surgery.1000912
Petropolis C, Kozan D, Sigurdson L. Accuracy of medical models made by consumer-grade fused deposition modelling printers. Plast Surg (Oakv). 2015;23(2):91-4. doi: 10.4172/plastic-surgery.1000912. PMID: 26090349; PMCID: PMC4459415.
Copy Download .nbib Format: NLM
Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient.

Breast cancer research and treatment

Churilla TM, Egleston BL, Murphy CT, Sigurdson ER, Hayes SB, Goldstein LJ, Bleicher RJ.
PMID: 27766452
Breast Cancer Res Treat. 2016 Dec;160(3):573. doi: 10.1007/s10549-016-4023-5.

No abstract available.

Cite
Churilla TM, Egleston BL, Murphy CT, et al. Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient. Breast Cancer Res Treat. 2016;160(3):573doi: 10.1007/s10549-016-4023-5.
Churilla, T. M., Egleston, B. L., Murphy, C. T., Sigurdson, E. R., Hayes, S. B., Goldstein, L. J., & Bleicher, R. J. (2016). Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient. Breast cancer research and treatment, 160(3), 573. https://doi.org/10.1007/s10549-016-4023-5
Churilla, Thomas M, et al. "Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient." Breast cancer research and treatment vol. 160,3 (2016): 573. doi: https://doi.org/10.1007/s10549-016-4023-5
Churilla TM, Egleston BL, Murphy CT, Sigurdson ER, Hayes SB, Goldstein LJ, Bleicher RJ. Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient. Breast Cancer Res Treat. 2016 Dec;160(3):573. doi: 10.1007/s10549-016-4023-5. PMID: 27766452.
Copy Download .nbib Format: NLM
Human prion protein sequence elements impede cross-species chronic wasting disease transmission.

The Journal of clinical investigation

Kurt TD, Jiang L, Fernández-Borges N, Bett C, Liu J, Yang T, Spraker TR, Castilla J, Eisenberg D, Kong Q, Sigurdson CJ.
PMID: 25961458
J Clin Invest. 2015 Jun;125(6):2548. doi: 10.1172/JCI82647. Epub 2015 May 11.

No abstract available.

Cite
Kurt TD, Jiang L, Fernández-Borges N, et al. Human prion protein sequence elements impede cross-species chronic wasting disease transmission. J Clin Invest. 2015;125(6):2548doi: 10.1172/JCI82647.
Kurt, T. D., Jiang, L., Fernández-Borges, N., Bett, C., Liu, J., Yang, T., Spraker, T. R., Castilla, J., Eisenberg, D., Kong, Q., & Sigurdson, C. J. (2015). Human prion protein sequence elements impede cross-species chronic wasting disease transmission. The Journal of clinical investigation, 125(6), 2548. https://doi.org/10.1172/JCI82647
Kurt, Timothy D, et al. "Human prion protein sequence elements impede cross-species chronic wasting disease transmission." The Journal of clinical investigation vol. 125,6 (2015): 2548. doi: https://doi.org/10.1172/JCI82647
Kurt TD, Jiang L, Fernández-Borges N, Bett C, Liu J, Yang T, Spraker TR, Castilla J, Eisenberg D, Kong Q, Sigurdson CJ. Human prion protein sequence elements impede cross-species chronic wasting disease transmission. J Clin Invest. 2015 Jun;125(6):2548. doi: 10.1172/JCI82647. Epub 2015 May 11. PMID: 25961458; PMCID: PMC4497774.
Copy Download .nbib Format: NLM
Cosmic 21 cm delensing of microwave background polarization and the minimum detectable energy scale of inflation.

Physical review letters

Sigurdson K, Cooray A.
PMID: 16384131
Phys Rev Lett. 2005 Nov 18;95(21):211303. doi: 10.1103/PhysRevLett.95.211303. Epub 2005 Nov 16.

We propose a new method for removing gravitational lensing from maps of cosmic microwave background (CMB) polarization anisotropies. Using observations of anisotropies or structures in the cosmic 21 cm radiation, emitted or absorbed by neutral hydrogen atoms at redshifts...

Cite
Sigurdson K, Cooray A. Cosmic 21 cm delensing of microwave background polarization and the minimum detectable energy scale of inflation. Phys Rev Lett. 2005;95(21):211303doi: 10.1103/PhysRevLett.95.211303.
Sigurdson, K., & Cooray, A. (2005). Cosmic 21 cm delensing of microwave background polarization and the minimum detectable energy scale of inflation. Physical review letters, 95(21), 211303. https://doi.org/10.1103/PhysRevLett.95.211303
Sigurdson, Kris, and Cooray, Asantha. "Cosmic 21 cm delensing of microwave background polarization and the minimum detectable energy scale of inflation." Physical review letters vol. 95,21 (2005): 211303. doi: https://doi.org/10.1103/PhysRevLett.95.211303
Sigurdson K, Cooray A. Cosmic 21 cm delensing of microwave background polarization and the minimum detectable energy scale of inflation. Phys Rev Lett. 2005 Nov 18;95(21):211303. doi: 10.1103/PhysRevLett.95.211303. Epub 2005 Nov 16. PMID: 16384131.
Copy Download .nbib Format: NLM
Measuring the primordial deuterium abundance during the cosmic dark ages.

Physical review letters

Sigurdson K, Furlanetto SR.
PMID: 17026353
Phys Rev Lett. 2006 Sep 01;97(9):091301. doi: 10.1103/PhysRevLett.97.091301. Epub 2006 Aug 29.

We discuss how measurements of fluctuations in the absorption of cosmic microwave background photons by neutral gas at redshifts z approximately 7-200 could reveal the primordial deuterium abundance of the Universe. The strength of the cross-correlation of brightness-temperature fluctuations...

Cite
Sigurdson K, Furlanetto SR. Measuring the primordial deuterium abundance during the cosmic dark ages. Phys Rev Lett. 2006;97(9):091301doi: 10.1103/PhysRevLett.97.091301.
Sigurdson, K., & Furlanetto, S. R. (2006). Measuring the primordial deuterium abundance during the cosmic dark ages. Physical review letters, 97(9), 091301. https://doi.org/10.1103/PhysRevLett.97.091301
Sigurdson, Kris, and Furlanetto, Steven R. "Measuring the primordial deuterium abundance during the cosmic dark ages." Physical review letters vol. 97,9 (2006): 091301. doi: https://doi.org/10.1103/PhysRevLett.97.091301
Sigurdson K, Furlanetto SR. Measuring the primordial deuterium abundance during the cosmic dark ages. Phys Rev Lett. 2006 Sep 01;97(9):091301. doi: 10.1103/PhysRevLett.97.091301. Epub 2006 Aug 29. PMID: 17026353.
Copy Download .nbib Format: NLM
ETHOS - an effective theory of structure formation: predictions for the high-redshift Universe - abundance of galaxies and reionization.

Monthly notices of the Royal Astronomical Society

Lovell MR, Zavala J, Vogelsberger M, Shen X, Cyr-Racine FY, Pfrommer C, Sigurdson K, Boylan-Kolchin M, Pillepich A.
PMID: 30598558
Mon Not R Astron Soc. 2018 Jul 01;477(3):2886-2899. doi: 10.1093/mnras/sty818. Epub 2018 Mar 28.

We contrast predictions for the high-redshift galaxy population and reionization history between cold dark matter (CDM) and an alternative self-interacting dark matter model based on the recently developed ETHOS framework that alleviates the small-scale CDM challenges within the Local...

Cite
Lovell MR, Zavala J, Vogelsberger M, et al. ETHOS - an effective theory of structure formation: predictions for the high-redshift Universe - abundance of galaxies and reionization. Mon Not R Astron Soc. 2018;477(3):2886-2899doi: 10.1093/mnras/sty818.
Lovell, M. R., Zavala, J., Vogelsberger, M., Shen, X., Cyr-Racine, F. Y., Pfrommer, C., Sigurdson, K., Boylan-Kolchin, M., & Pillepich, A. (2018). ETHOS - an effective theory of structure formation: predictions for the high-redshift Universe - abundance of galaxies and reionization. Monthly notices of the Royal Astronomical Society, 477(3), 2886-2899. https://doi.org/10.1093/mnras/sty818
Lovell, Mark R, et al. "ETHOS - an effective theory of structure formation: predictions for the high-redshift Universe - abundance of galaxies and reionization." Monthly notices of the Royal Astronomical Society vol. 477,3 (2018): 2886-2899. doi: https://doi.org/10.1093/mnras/sty818
Lovell MR, Zavala J, Vogelsberger M, Shen X, Cyr-Racine FY, Pfrommer C, Sigurdson K, Boylan-Kolchin M, Pillepich A. ETHOS - an effective theory of structure formation: predictions for the high-redshift Universe - abundance of galaxies and reionization. Mon Not R Astron Soc. 2018 Jul 01;477(3):2886-2899. doi: 10.1093/mnras/sty818. Epub 2018 Mar 28. PMID: 30598558; PMCID: PMC6310026.
Copy Download .nbib Format: NLM
Applying the PAI Treatment Process Index to PAI-As Completed by Adolescents in a Residential Program.

Assessment

Charles NE, Floyd PN, Bullerjahn MR, Sigurdson L, Barry CT.
PMID: 34388939
Assessment. 2021 Aug 13;10731911211038061. doi: 10.1177/10731911211038061. Epub 2021 Aug 13.

The Personality Assessment Inventory (PAI) Treatment Process Index (TPI) is a measure of treatment amenability based on an index of factors related to poor treatment outcomes (e.g., hostility, lack of social support, and poor impulse control). In this study,...

Cite
Charles NE, Floyd PN, Bullerjahn MR, et al. Applying the PAI Treatment Process Index to PAI-As Completed by Adolescents in a Residential Program. Assessment. 2021;10731911211038061doi: 10.1177/10731911211038061.
Charles, N. E., Floyd, P. N., Bullerjahn, M. R., Sigurdson, L., & Barry, C. T. (2021). Applying the PAI Treatment Process Index to PAI-As Completed by Adolescents in a Residential Program. Assessment, 10731911211038061. https://doi.org/10.1177/10731911211038061
Charles, Nora E, et al. "Applying the PAI Treatment Process Index to PAI-As Completed by Adolescents in a Residential Program." Assessment vol. (2021): 10731911211038061. doi: https://doi.org/10.1177/10731911211038061
Charles NE, Floyd PN, Bullerjahn MR, Sigurdson L, Barry CT. Applying the PAI Treatment Process Index to PAI-As Completed by Adolescents in a Residential Program. Assessment. 2021 Aug 13;10731911211038061. doi: 10.1177/10731911211038061. Epub 2021 Aug 13. PMID: 34388939.
Copy Download .nbib Format: NLM
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial.

JAMA oncology

Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, Moxley KM, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ, Abd-El-Khalick F.
PMID: 34196693
JAMA Oncol. 2021 Aug 01;7(8):1225-1230. doi: 10.1001/jamaoncol.2021.1683.

IMPORTANCE: Total neoadjuvant therapy (TNT) is often used to downstage locally advanced rectal cancer (LARC) and decrease locoregional relapse; however, more than one-third of patients develop recurrent metastatic disease. As such, novel combinations are needed.OBJECTIVE: To assess whether the...

Cite
Rahma OE, Yothers G, Hong TS, et al. Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. JAMA Oncol. 2021;7(8):1225-1230doi: 10.1001/jamaoncol.2021.1683.
Rahma, O. E., Yothers, G., Hong, T. S., Russell, M. M., You, Y. N., Parker, W., Jacobs, S. A., Colangelo, L. H., Lucas, P. C., Gollub, M. J., Hall, W. A., Kachnic, L. A., Vijayvergia, N., O'Rourke, M. A., Faller, B. A., Valicenti, R. K., Schefter, T. E., Moxley, K. M., Kainthla, R., Stella, P. J., Sigurdson, E., Wolmark, N., George, T. J., & Abd-El-Khalick, F. (2021). Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. JAMA oncology, 7(8), 1225-1230. https://doi.org/10.1001/jamaoncol.2021.1683
Rahma, Osama E, et al. "Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial." JAMA oncology vol. 7,8 (2021): 1225-1230. doi: https://doi.org/10.1001/jamaoncol.2021.1683
Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, Moxley KM, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ, Abd-El-Khalick F. Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. JAMA Oncol. 2021 Aug 01;7(8):1225-1230. doi: 10.1001/jamaoncol.2021.1683. PMID: 34196693; PMCID: PMC8251652.
Copy Download .nbib Format: NLM
One Fraction Size Does Not Fit All: Patient Preferences for Hypofractionated Radiation Therapy From a Discrete Choice Experiment.

Practical radiation oncology

Sigurdson S, Harrison M, Pearce A, Richardson H, Zaza K, Brundage M.
PMID: 34991857
Pract Radiat Oncol. 2022 Jan-Feb;12(1):e24-e33. doi: 10.1016/j.prro.2021.08.012.

PURPOSE: Hypofractionated external beam radiation therapy (EBRT) is a standard of care option for localized prostate cancer. To inform clinical practice we quantified patients' preferences for convenience, efficacy, and toxicity risks, of conventional, moderate hypofractionation, and stereotactic radiation therapy...

Cite
Sigurdson S, Harrison M, Pearce A, et al. One Fraction Size Does Not Fit All: Patient Preferences for Hypofractionated Radiation Therapy From a Discrete Choice Experiment. Pract Radiat Oncol. 2022;12(1):e24-e33doi: 10.1016/j.prro.2021.08.012.
Sigurdson, S., Harrison, M., Pearce, A., Richardson, H., Zaza, K., & Brundage, M. (2022). One Fraction Size Does Not Fit All: Patient Preferences for Hypofractionated Radiation Therapy From a Discrete Choice Experiment. Practical radiation oncology, 12(1), e24-e33. https://doi.org/10.1016/j.prro.2021.08.012
Sigurdson, Samantha, et al. "One Fraction Size Does Not Fit All: Patient Preferences for Hypofractionated Radiation Therapy From a Discrete Choice Experiment." Practical radiation oncology vol. 12,1 (2022): e24-e33. doi: https://doi.org/10.1016/j.prro.2021.08.012
Sigurdson S, Harrison M, Pearce A, Richardson H, Zaza K, Brundage M. One Fraction Size Does Not Fit All: Patient Preferences for Hypofractionated Radiation Therapy From a Discrete Choice Experiment. Pract Radiat Oncol. 2022 Jan-Feb;12(1):e24-e33. doi: 10.1016/j.prro.2021.08.012. PMID: 34991857.
Copy Download .nbib Format: NLM
A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis.

Cancers

Yan M, Sigurdson S, Greifer N, Kennedy TAC, Toh TS, Lindsay PE, Weiss J, Hueniken K, Yeung C, Sugumar V, Sun A, Bezjak A, Cho BCJ, Raman S, Hope AJ, Giuliani ME, Stuart EA, Owen T, Ashworth A, Robinson A, de Moraes FY, Liu G, Lok BH.
PMID: 34207857
Cancers (Basel). 2021 Jun 09;13(12). doi: 10.3390/cancers13122895.

Despite evidence for the superiority of twice-daily (BID) radiotherapy schedules, their utilization in practice remains logistically challenging. Hypofractionation (HFRT) is a commonly implemented alternative. We aim to compare the outcomes and toxicities in limited-stage small-cell lung cancer (LS-SCLC) patients...

Cite
Yan M, Sigurdson S, Greifer N, et al. A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis. Cancers (Basel). 2021;13(12)doi: 10.3390/cancers13122895.
Yan, M., Sigurdson, S., Greifer, N., Kennedy, T. A. C., Toh, T. S., Lindsay, P. E., Weiss, J., Hueniken, K., Yeung, C., Sugumar, V., Sun, A., Bezjak, A., Cho, B. C. J., Raman, S., Hope, A. J., Giuliani, M. E., Stuart, E. A., Owen, T., Ashworth, A., Robinson, A., de Moraes, F. Y., Liu, G., & Lok, B. H. (2021). A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis. Cancers, 13(12), . https://doi.org/10.3390/cancers13122895
Yan, Michael, et al. "A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis." Cancers vol. 13,12 (2021). doi: https://doi.org/10.3390/cancers13122895
Yan M, Sigurdson S, Greifer N, Kennedy TAC, Toh TS, Lindsay PE, Weiss J, Hueniken K, Yeung C, Sugumar V, Sun A, Bezjak A, Cho BCJ, Raman S, Hope AJ, Giuliani ME, Stuart EA, Owen T, Ashworth A, Robinson A, de Moraes FY, Liu G, Lok BH. A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis. Cancers (Basel). 2021 Jun 09;13(12). doi: 10.3390/cancers13122895. PMID: 34207857; PMCID: PMC8229231.
Copy Download .nbib Format: NLM
Correction: Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders.

The Journal of biological chemistry

Hackshaw KV, Aykas DP, Sigurdson GT, Plans M, Madiai F, Yu L, Buffington CAT, Giusti MM, Rodriguez-Saona L.
PMID: 32332131
J Biol Chem. 2020 Apr 24;295(17):5834. doi: 10.1074/jbc.AAC120.013667.

No abstract available.

Cite
Hackshaw KV, Aykas DP, Sigurdson GT, et al. Correction: Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders. J Biol Chem. 2020;295(17):5834doi: 10.1074/jbc.AAC120.013667.
Hackshaw, K. V., Aykas, D. P., Sigurdson, G. T., Plans, M., Madiai, F., Yu, L., Buffington, C. A. T., Giusti, M. M., & Rodriguez-Saona, L. (2020). Correction: Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders. The Journal of biological chemistry, 295(17), 5834. https://doi.org/10.1074/jbc.AAC120.013667
Hackshaw, Kevin V, et al. "Correction: Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders." The Journal of biological chemistry vol. 295,17 (2020): 5834. doi: https://doi.org/10.1074/jbc.AAC120.013667
Hackshaw KV, Aykas DP, Sigurdson GT, Plans M, Madiai F, Yu L, Buffington CAT, Giusti MM, Rodriguez-Saona L. Correction: Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders. J Biol Chem. 2020 Apr 24;295(17):5834. doi: 10.1074/jbc.AAC120.013667. PMID: 32332131; PMCID: PMC7186174.
Copy Download .nbib Format: NLM
A Soluble PrP.

Journal of immunology (Baltimore, Md. : 1950)

Mantuano E, Azmoon P, Banki MA, Sigurdson CJ, Campana WM, Gonias SL.
PMID: 34810220
J Immunol. 2022 Jan 01;208(1):85-96. doi: 10.4049/jimmunol.2100412. Epub 2021 Nov 22.

Nonpathogenic cellular prion protein (PrP

Cite
Mantuano E, Azmoon P, Banki MA, et al. A Soluble PrP. J Immunol. 2021;208(1):85-96doi: 10.4049/jimmunol.2100412.
Mantuano, E., Azmoon, P., Banki, M. A., Sigurdson, C. J., Campana, W. M., & Gonias, S. L. (2022). A Soluble PrP. Journal of immunology (Baltimore, Md. : 1950), 208(1), 85-96. https://doi.org/10.4049/jimmunol.2100412
Mantuano, Elisabetta, et al. "A Soluble PrP." Journal of immunology (Baltimore, Md. : 1950) vol. 208,1 (2022): 85-96. doi: https://doi.org/10.4049/jimmunol.2100412
Mantuano E, Azmoon P, Banki MA, Sigurdson CJ, Campana WM, Gonias SL. A Soluble PrP. J Immunol. 2022 Jan 01;208(1):85-96. doi: 10.4049/jimmunol.2100412. Epub 2021 Nov 22. PMID: 34810220.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 70 entries